Longevity & AgingResearch PaperOpen Access

Influenza Triggers Rare Brain Disease in Children Across US Hospitals

Multi-center study reveals clinical patterns and outcomes of influenza-associated acute necrotizing encephalopathy in pediatric patients.

Monday, April 6, 2026 0 views
Published in JAMA
Cross-section of a child's brain showing bilateral thalamic lesions highlighted in red against normal brain tissue, with influenza virus particles floating nearby

Summary

A comprehensive multi-center study examined influenza-associated acute necrotizing encephalopathy (IA-ANE), a rare but severe brain complication in children. Researchers analyzed 85 cases across 31 US hospitals, finding that this condition primarily affects previously healthy children with median age of 6 years. The disease causes rapid neurological deterioration with characteristic brain lesions visible on MRI. Despite intensive treatment, mortality reached 15% with many survivors experiencing significant neurological disabilities. Early recognition and supportive care remain the primary interventions, highlighting the importance of influenza vaccination and prompt medical attention for children with flu symptoms who develop altered mental status.

Detailed Summary

Influenza-associated acute necrotizing encephalopathy (IA-ANE) represents one of the most severe neurological complications of influenza infection in children, yet comprehensive data on this rare condition has been limited. This landmark multi-center study provides the most extensive analysis to date of IA-ANE in US pediatric populations.

Researchers from the IA-ANE Working Group analyzed 85 confirmed cases across 31 hospitals from 2009-2019, representing the largest cohort study of this condition. The study employed strict diagnostic criteria including confirmed influenza infection, acute encephalopathy with altered consciousness, and characteristic bilateral brain lesions on neuroimaging.

Key findings revealed that IA-ANE predominantly affects previously healthy children with a median age of 6 years, showing no significant gender preference. The condition typically presents within days of influenza onset, with rapid progression to altered mental status, seizures, and coma. Neuroimaging consistently showed bilateral symmetric lesions in the thalamus, brainstem, and other deep brain structures - the hallmark of this devastating condition.

Clinical outcomes were sobering, with 15% mortality and significant morbidity among survivors. Most children required intensive care support, with many developing refractory seizures and requiring mechanical ventilation. Long-term follow-up revealed persistent neurological deficits in the majority of survivors, including cognitive impairment, motor dysfunction, and ongoing seizure disorders.

The study's implications extend beyond clinical recognition to public health policy. The findings underscore the critical importance of influenza vaccination as a primary prevention strategy, particularly given that most affected children were previously healthy. Additionally, the research highlights the need for rapid recognition and aggressive supportive care when children with influenza develop neurological symptoms, though specific targeted therapies remain elusive.

Key Findings

  • 85 cases analyzed across 31 US hospitals over 10-year period
  • 15% mortality rate with significant neurological morbidity in survivors
  • Median age 6 years, predominantly affecting previously healthy children
  • Bilateral thalamic lesions characteristic on brain MRI imaging
  • Rapid progression from flu symptoms to severe encephalopathy within days

Methodology

Multi-center retrospective cohort study analyzing 85 confirmed IA-ANE cases from 31 US hospitals between 2009-2019. Cases required laboratory-confirmed influenza, acute encephalopathy with altered consciousness, and characteristic bilateral brain lesions on neuroimaging.

Study Limitations

Retrospective design may introduce selection bias toward more severe cases. Long-term outcome data was limited for some patients. The study focused on hospitalized cases, potentially missing milder presentations of the condition.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.